Skip to main content
. 2022 Mar;11(3):569–579. doi: 10.21037/tcr-22-344

Figure 7.

Figure 7

Funnel plot of the therapeutic efficacy of CAR-T therapy for RRMM. CAR, chimeric antigen receptor; RRMM, relapsed or refractory multiple myeloma.